# FDA Approves Viatris Norelgestromin and Ethinyl Estradiol Contraceptive Patch

> fda · REPORTED · 2026-07-29

On July 29, 2026, the FDA approved Viatris's norelgestromin and ethinyl estradiol contraceptive product, adding a new patient-centered contraceptive option for women. The approval was part of a broader wave of FDA decisions in July 2026 covering women's health and preventive care.

About Viatris: Viatris is a global pharmaceutical company that develops, manufactures, and commercializes a broad range of branded and generic medicines including contraceptives, serving women's health and primary care markets worldwide.

- Company: Viatris
- Sector: women's health
- Primary source: https://www.patientcareonline.com/view/5-fda-decisions-for-primary-care-to-know-from-july-2026

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.